Knowledge Obtained from an Elderly Case of Japanese Encephalitis

Intern Med. 2016;55(17):2487-90. doi: 10.2169/internalmedicine.55.6646. Epub 2016 Sep 1.

Abstract

The nationwide introduction of a Japanese encephalitis (JE) vaccine has contributed to a reduction in the annual infection rate of JE in Japan. However, the current neutralizing antibody prevalence ratio in Japan is approximately 20% in children 3-4 years of age and in people in their forties and fifties. We herein report a man with JE who was definitively diagnosed by multi-virus real-time polymerase chain reaction employing biopsied brain tissue and serological examinations. JE should be kept in mind when a patient has severe encephalitis of unknown etiology. In order to protect the susceptible population from JE, vaccination is recommended, especially for children and middle-aged people.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Viral / immunology
  • Biopsy
  • Encephalitis, Japanese / diagnosis*
  • Humans
  • Japan
  • Male
  • Real-Time Polymerase Chain Reaction

Substances

  • Antibodies, Viral